Drug Levels and Effects:

Summary of Use during Lactation:

Many reviews state thattetracyclinesare contraindicated during breastfeeding because of possible staining of infants' dental enamel or bone deposition oftetracyclines. However, a close examination of available literature indicates that there is not likely to be harm in short-term use of minocycline during lactation because milk levels are low and absorption by the infant is inhibited by the calcium in breastmilk. Short-term use of minocycline is acceptable in nursing mothers. As a theoretical precaution, avoid prolonged or repeat courses during nursing. Monitor the infant for rash and for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis (thrush, diaper rash). Black discoloration of breastmilk has been reported with minocycline.

Drug Levels:

Maternal Levels.

After a single dose of minocycline 200 mg orally in 2 patients (time postpartum not stated), a peak milk level of 0.8 mg/L occurred at 6 hours after the dose. Average milk levels ranged between 0.5 and 0.8 mg/L during the 12 hours after the dose and a total of 18 mcg was excreted during this time.[1]

Infant Levels.

Relevant published information was not found as of the revision date.

Effects in Breastfed Infants:

Relevant published information was not found as of the revision date.

Possible Effects on Lactation:

A woman taking minocycline 100 mg twice daily for almost 4 years developed galactorrhea after taking perphenazine, amitriptyline and diphenhydramine, and the breast secretion was black in color.[2]

Another woman who had nursed her infant and produced occasional small amounts of breastmilk during the 18 months after weaning was given oral minocycline 150 mg daily. After 3 to 4 weeks, expressed milk had become black. Iron levels in milk were over 100 times greater than that found in normal milk. A mammogram was normal.[3]

In both of these cases, macrophages containing a black, iron-containing pigment were found in milk. It is thought that the pigment is an iron chelate of minocycline or one of its metabolites.[2][3]

Alternate Drugs to Consider:



1. Mizuno S, Taketa M, Sano S et al. Minocycline. Jpn J Antibiot. 1969;22:473-9. PMID:4909972
2. Basler RSW, Lynch PJ. Black galactorrhea as a consequence of minocycline and phenothiazine therapy. Arch Dermatol. 1985;121:417-8. PMID:4038862
3. Hunt MJ, Salisbury ELC, Grace J, Armati R. Black breast milk due to minocycline therapy. Br J Dermatol. 1996;134:943-44. PMID:8736342

Substance Identification:

Substance Name:


CAS Registry Number:


Drug Class:

  • Antiinfective Agents

  • Antibacterial Agents

  • Tetracyclines

    Administrative Information:

    LactMed Record Number:


    Last Revision Date:

    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.